株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

造影剤注入装置の世界市場 - 2021年までの予測:CT用造影剤注入装置、MRI用造影剤注入装置、消耗品、付属品

Contrast Injector Market by Product (Injector Systems (CT Injector, MRI Injector), Consumables (Injector Head, Tubing), Accessories), & Application (Radiology, Interventional Cardiology, Interventional Radiology) - Global Forecast to 2021

発行 MarketsandMarkets 商品コード 502189
出版日 ページ情報 英文 128 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.66円で換算しております。
Back to Top
造影剤注入装置の世界市場 - 2021年までの予測:CT用造影剤注入装置、MRI用造影剤注入装置、消耗品、付属品 Contrast Injector Market by Product (Injector Systems (CT Injector, MRI Injector), Consumables (Injector Head, Tubing), Accessories), & Application (Radiology, Interventional Cardiology, Interventional Radiology) - Global Forecast to 2021
出版日: 2017年05月10日 ページ情報: 英文 128 Pages
概要

造影剤注入装置市場は、2016年の4億4550万米ドルから、2021年までに6億3610万米ドルまで拡大すると見られています。市場は、2016年〜2021年のCAGR (複合年間成長率) で、7.4%の成長が予測されています。

当レポートでは、世界の造影剤注入装置市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 造影剤注入装置:市場概要
  • 造影剤注入装置市場:用途別、製品別
  • 造影剤注入装置市場:用途別、地域別
  • 地域別スナップショット:造影剤注入装置市場

第5章 造影剤注入装置の世界市場:概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題

第6章 造影剤注入装置の世界市場:製品別

  • イントロダクション
  • 注入装置
    • CT用
    • MRI用
    • AG用
  • 消耗品
    • ヘッド
    • シリンジ
    • チューブ
    • その他
  • 付属品

第7章 造影剤注入装置の世界市場:用途別

  • イントロダクション
  • 放射線学
  • 心血管インターベンション
  • インターベンショナルラジオロジー (IVR)

第8章 造影剤注入装置の世界市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第9章 競合情勢

  • 概要
  • 市場シェア分析
  • 競合シナリオ

第10章 企業プロファイル

  • BAYER AG (MEDRAD INC.)
  • BRACCO IMAGING S.P.A.
  • GUERBET GROUP
  • ULRICH GMBH & CO. KG.
  • 根本杏林堂
  • SINO MEDICAL-DEVICE TECHNOLOGY CO., LTD. (SINOMDT)
  • APOLLO RT CO., LTD.
  • VIVID IMAGING
  • ANGIODYNAMICS (NAVILYST MEDICAL, INC)
  • GE HEALTHCARE

第11章 付録

目次
Product Code: MD 5244

The contrast injector market is projected to reach USD 636.1 million by 2021 from USD 445.5 million in 2016, growing at a CAGR of 7.4% in the next five years (2016 to 2021).

The contrast injector market growth can primarily be attributed to factors such as the large number of approvals for contrast agents in different geographies and increasing number of public and private diagnostic centers. On the other hand, the side effects and allergic reactions associated with contrast agents are expected to limit the market growth to a certain extent.

The global contrast injector market is segmented on the basis of product, application, and region. In 2016, North America is expected to account for the largest share of the global contrast injector market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Asia-Pacific is projected to have the highest growth rate in the forecast period. The high growth rate of this segment can be attributed to factors such as rising aging population and cancer incidences, expansion of international players in China and India, increasing R&D investments in China, and favorable regulatory changes in New Zealand and Australia.

The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (market developments (product approvals); product deployment; product launch; and other strategies (grants, award & recognition, investment, expansion, agreements, and acquisitions) to increase their market shares and establish a strong foothold in the global market.

In-depth interviews were conducted with CEOs, sales and marketing directors, other innovation and technology directors, and executives from various key organizations operating in the contrast injector market.

  • By Company Type: Tier 1: 10%, Tier 2: 63%, Tier 3: 27%
  • By Designation: Director Level: 19%, C-level: 28%, Others: 53%
  • By Region: North America: 27%, Europe: 27%, APAC: 30%, RoW: 16%

Key players in the global contrast injector market include Bracco Imaging S.p.A (Italy), Bayer HealthCare (Germany), Guerbet Group (France), GE Healthcare (U.S.), ulrich GmbH & Co. KG, (Germany), Nemoto Kyorindo Co., Ltd. (Japan), Sino Medical- Device Technology Co., Ltd. (China), Apollo RT Co., Ltd. (China), VIVID IMAGING (China), and AngioDynamics(U.S.)

Research Coverage:

The report provides a picture of the contrast injector market across different industry verticals and regions. It aims at estimating the market size and future growth potential of this market across different segments such as by product, application, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, product pipeline, and key market strategies.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the products and services offered by top players in the contrast injector market. The report analyzes the contrast media injector by product, application, and region.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the contrast injector market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for contrast injectors across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the contrast injector market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and distribution networks of the leading players in the contrast injector market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
    • 2.1.1. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
      • 2.1.1.1. Secondary research
        • 2.1.1.1.1. Key data from secondary sources
      • 2.1.1.2. Primary research
        • 2.1.1.2.1. Key Insights from primary sources
      • 2.1.1.3. Key industry insights
    • 2.1.2. MARKET SIZE ESTIMATION METHODOLOGY
    • 2.1.3. RESEARCH DESIGN
    • 2.1.4. MARKET DATA VALIDATION AND TRIANGULATION
    • 2.1.5. ASSUMPTIONS

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. CONTRAST MEDIA INJECTORS: MARKET OVERVIEW
  • 4.2. CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION AND BY PRODUCT
  • 4.3. CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION AND BY REGION
  • 4.4. GEOGRAPHIC SNAPSHOT: CONTRAST MEDIA INJECTORS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Large number of approvals for contrast agents
      • 5.2.1.2. Increasing number of public and private diagnostic centers
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Risks associated with contrast media injectors
      • 5.2.2.2. High cost of contrast media injectors and consumables & accessories
      • 5.2.2.3. Reluctance to adopt new technology
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Technological advancements in contrast media injectors arena
        • 5.2.3.1.1. IT-enabled solutions for contrast media injectors
        • 5.2.3.1.2. Syringeless and dual-head injectors
      • 5.2.3.2. Increasing focus of market players on contrast media injector arena
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Development of gamma and neutron imaging solutions
      • 5.2.4.2. Shortage of and need for highly skilled professionals
      • 5.2.4.3. Development of biomarkers

6. GLOBAL CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. INJECTOR SYSTEMS
    • 6.2.1. CT INJECTOR SYSTEMS
    • 6.2.2. MRI INJECTOR SYSTEMS
    • 6.2.3. ANGIOGRAPHY INJECTOR SYSTEMS
  • 6.3. CONSUMABLES
    • 6.3.1. INJECTOR HEADS
      • 6.3.1.1. Single head injectors
      • 6.3.1.2. Dual head injectors
      • 6.3.1.3. Syringeless injectors
    • 6.3.2. SYRINGES
    • 6.3.3. TUBING
    • 6.3.4. OTHER CONSUMABLES
  • 6.4. ACCESSORIES

7. GLOBAL CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. RADIOLOGY
  • 7.3. INTERVENTIONAL CARDIOLOGY
  • 7.4. INTERVENTIONAL RADIOLOGY

8. CONTRAST MEDIA INJECTORS MARKET, BY REGION

  • 8.1. INTRODUCTION
  • 8.2. NORTH AMERICA
    • 8.2.1. U.S.
      • 8.2.1.1. Increasing number of diagnostic imaging tests and centers
      • 8.2.1.2. Rising prevalence of chronic diseases and increasing aging population
      • 8.2.1.3. Prevalence of Alzheimer's disease and other dementias
    • 8.2.2. CANADA
      • 8.2.2.1. Rising aging population, high incidence of cancer, CVD, and diabetes
      • 8.2.2.2. MRI and CT examinations likely to boost the market
      • 8.2.2.3. Increasing number of cardiac arrest cases
  • 8.3. EUROPE
    • 8.3.1. EUROPE 3
      • 8.3.1.1. Germany: increasing number of diagnostic imaging procedures
      • 8.3.1.2. France: increasing incidences and prevalence of cancer
      • 8.3.1.3. U.K.: lack of sufficient instruments
    • 8.3.2. ROE
      • 8.3.2.1. Increased focus of market players on RoE countries
      • 8.3.2.2. Russia: Initiatives by government to improve healthcare
  • 8.4. ASIA-PACIFIC
    • 8.4.1. RISE IN AGING POPULATION AND CANCER INCIDENCE
    • 8.4.2. EXPANSION OF INTERNATIONAL PLAYERS IN CHINA AND INDIA
    • 8.4.3. FAVORABLE REGULATORY CHANGES IN NEW ZEALAND AND AUSTRALIA
    • 8.4.4. HEALTHCARE REFORMS, GOVERNMENT INITIATIVES, AND INVESTMENTS IN CHINA
  • 8.5. REST OF THE WORLD
    • 8.5.1. LATIN AMERICA
    • 8.5.2. THE MIDDLE EAST
    • 8.5.3. AFRICA

9. COMPETITIVE LANDSCAPE

  • 9.1. OVERVIEW
  • 9.2. MARKET SHARE ANALYSIS
    • 9.2.1. BRACCO IMAGING S.P.A
    • 9.2.2. BAYER HEALTHCARE
    • 9.2.3. GUERBET GROUP
  • 9.3. COMPETITIVE SCENARIO
    • 9.3.1. OTHER STRATEGIES
    • 9.3.2. PRODUCT DEPLOYMENT
    • 9.3.3. PRODUCT LAUNCH
    • 9.3.4. MARKET DEVELOPMENTS (PRODUCT APPROVALS)

10. COMPANY PROFILES (Overview, Financial*, Products & Services, Strategy, and Developments)

  • 10.1. BAYER AG (MEDRAD INC.)
  • 10.2. BRACCO IMAGING S.P.A.
  • 10.3. GUERBET GROUP
  • 10.4. ULRICH GMBH & CO. KG.
  • 10.5. NEMOTO KYORINDO CO., LTD
  • 10.6. SINO MEDICAL-DEVICE TECHNOLOGY CO., LTD. (SINOMDT)
  • 10.7. APOLLO RT CO., LTD.
  • 10.8. VIVID IMAGING
  • 10.9. ANGIODYNAMICS (NAVILYST MEDICAL, INC)
  • 10.10. GE HEALTHCARE

*Details might not be captured in case of unlisted companies.

11. APPENDIX

  • 11.1. DISCUSSION GUIDE
  • 11.2. KNOWLEDGE STORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL
  • 11.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 11.4. AVAILABLE CUSTOMIZATIONS
  • 11.5. RELATED REPORTS
  • 11.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL CONTRAST MEDIA INJECTORS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 2: CONTRAST MEDIA INJECTOR SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 3: CONTRAST MEDIA INJECTOR SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 4: CONTRAST MEDIA CT INJECTOR SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 5: CONTRAST MEDIA MRI INJECTOR SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 6: CONTRAST MEDIA ANGIOGRAPHY INJECTOR SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: CONTRAST MEDIA INJECTOR CONSUMABLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 8: CONTRAST MEDIA INJECTOR CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 9: CONTRAST MEDIA INJECTOR HEADS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: CONTRAST MEDIA INJECTOR HEADS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 11: SINGLE HEAD INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: DUAL HEAD INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: SYRINGELESS INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: CONTRAST MEDIA INJECTOR SYRINGES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: CONTRAST MEDIA INJECTOR TUBING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: OTHER CONTRAST MEDIA INJECTOR CONSUMABLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 17: CONTRAST MEDIA INJECTOR ACCESSORIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: CONTRAST MEDIA INJECTORS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 19: CONTRAST MEDIA INJECTORS MARKET SIZE FOR RADIOLOGY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: CONTRAST MEDIA INJECTORS MARKET SIZE FOR INTERVENTIONAL CARDIOLOGY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: CONTRAST MEDIA INJECTORS MARKET SIZE FOR INTERVENTIONAL RADIOLOGY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: CONTRAST MEDIA INJECTOR MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: NORTH AMERICA: CONTRAST MEDIA INJECTOR MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 24: NORTH AMERICA: CONTRAST MEDIA INJECTOR MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 25: NORTH AMERICA: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR SYSTEM TYPE, 2014-2021 (USD MILLION)
  • TABLE 26: NORTH AMERICA: CONTRAST MEDIA INJECTOR MARKET SIZE, BY CONSUMABLES TYPE, 2014-2021 (USD MILLION)
  • TABLE 27: NORTH AMERICA: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR HEAD TYPE, 2014-2021 (USD MILLION)
  • TABLE 28: NORTH AMERICA: CONTRAST MEDIA INJECTOR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 29: U.S.: CONTRAST MEDIA INJECTOR MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 30: U.S.: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR SYSTEM TYPE, 2014-2021 (USD MILLION)
  • TABLE 31: U.S.: CONTRAST MEDIA INJECTOR MARKET SIZE, BY CONSUMABLES TYPE, 2014-2021 (USD MILLION)
  • TABLE 32: U.S.: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR HEAD TYPE, 2014-2021 (USD MILLION)
  • TABLE 33: U.S.: CONTRAST MEDIA INJECTOR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 34: CANADA: CONTRAST MEDIA INJECTOR MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 35: CANADA: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR SYSTEM TYPE, 2014-2021 (USD MILLION)
  • TABLE 36: CANADA: CONTRAST MEDIA INJECTOR MARKET SIZE, BY CONSUMABLES TYPE, 2014-2021 (USD MILLION)
  • TABLE 37: CANADA: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR HEAD TYPE, 2014-2021 (USD MILLION)
  • TABLE 38: CANADA: CONTRAST MEDIA INJECTOR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 39: EUROPE: CONTRAST MEDIA INJECTOR MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 40: EUROPE: CONTRAST MEDIA INJECTOR MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 41: EUROPE: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR SYSTEM TYPE, 2014-2021 (USD MILLION)
  • TABLE 42: EUROPE: CONTRAST MEDIA INJECTOR MARKET SIZE, BY CONSUMABLES TYPE, 2014-2021 (USD MILLION)
  • TABLE 43: EUROPE: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR HEAD TYPE, 2014-2021 (USD MILLION)
  • TABLE 44: EUROPE: CONTRAST MEDIA INJECTOR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 45: EUROPE 3: CONTRAST MEDIA INJECTOR MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 46: EUROPE 3: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR SYSTEM TYPE, 2014-2021 (USD MILLION)
  • TABLE 47: EUROPE 3: CONTRAST MEDIA INJECTOR MARKET SIZE, BY CONSUMABLES TYPE, 2014-2021 (USD MILLION)
  • TABLE 48: EUROPE 3: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR HEAD TYPE, 2014-2021 (USD MILLION)
  • TABLE 49: EUROPE 3: CONTRAST MEDIA INJECTOR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 50: ROE: CONTRAST MEDIA INJECTOR MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 51: ROE: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR SYSTEM TYPE, 2014-2021 (USD MILLION)
  • TABLE 52: ROE: CONTRAST MEDIA INJECTOR MARKET SIZE, BY CONSUMABLES TYPE, 2014-2021 (USD MILLION)
  • TABLE 53: ROE: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR HEAD TYPE, 2014-2021 (USD MILLION)
  • TABLE 54: ROE: CONTRAST MEDIA INJECTOR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 55: ASIA-PACIFIC: CONTRAST MEDIA INJECTOR MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 56: ASIA-PACIFIC: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR SYSTEM TYPE, 2014-2021 (USD MILLION)
  • TABLE 57: ASIA-PACIFIC: CONTRAST MEDIA INJECTOR MARKET SIZE, BY CONSUMABLES TYPE, 2014-2021 (USD MILLION)
  • TABLE 58: ASIA-PACIFIC: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR HEAD TYPE, 2014-2021 (USD MILLION)
  • TABLE 59: ASIA-PACIFIC: CONTRAST MEDIA INJECTOR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 60: ROW: CONTRAST MEDIA INJECTOR MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 61: ROW: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR SYSTEM TYPE, 2014-2021 (USD MILLION)
  • TABLE 62: ROW: CONTRAST MEDIA INJECTOR MARKET SIZE, BY CONSUMABLES TYPE, 2014-2021 (USD MILLION)
  • TABLE 63: ROW: CONTRAST MEDIA INJECTOR MARKET SIZE, BY INJECTOR HEAD TYPE, 2014-2021 (USD MILLION)
  • TABLE 64: ROW: CONTRAST MEDIA INJECTOR MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 65: KEY PLAYER'S RANKING IN THE CONTRAST MEDIA INJECTOR MARKET (2016)
  • TABLE 66: OTHER STRATEGIES, 2014-2016
  • TABLE 67: PRODUCT DEPLOYMENT, 2014-2016
  • TABLE 68: PRODUCT LAUNCH, 2013-2016
  • TABLE 69: MARKET DEVELOPMENTS (PRODUCT APPROVALS), 2013-2016

LIST OF FIGURES

  • FIGURE 1: RESEARCH METHODOLOGY: GLOBAL CONTRAST MEDIA INJECTORS MARKET
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: SAMPLING FRAME: PRIMARY RESEARCH
  • FIGURE 4: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 6: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 7: RESEARCH DESIGN: GLOBAL CONTRAST MEDIA INJECTORS MARKET
  • FIGURE 8: DATA TRIANGULATION METHODOLOGY
  • FIGURE 9: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT
  • FIGURE 10: CONTRAST MEDIA INJECTORS MARKET ANALYSIS, BY APPLICATION, 2016 VS. 2021
  • FIGURE 11: ASIA-PACIFIC IS EXPECTED TO WITNESS THE HIGHEST GROWTH IN THE CONTRAST MEDIA INJECTORS MARKET DURING THE FORECAST PERIOD
  • FIGURE 12: NORTH AMERICA ESTIMATED TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2016
  • FIGURE 13: CONSUMABLES SEGMENT ESTIMATED TO LEAD THE MARKET IN 2016
  • FIGURE 14: RADIOLOGY IS ESTIMATED TO BE THE LARGEST APPLICATION, 2016
  • FIGURE 15: ASIA-PACIFIC TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 16: DRIVERS, RESTRAINTS, OPPORTUNITIES & CHALLENGES
  • FIGURE 17: THE CONSUMABLES SEGMENT IS THE FASTEST-GROWING PRODUCT SEGMENT OF THE GLOBAL CONTRAST MEDIA INJECTORS MARKET
  • FIGURE 18: RADIOLOGY TO ACCOUNT FOR THE LARGEST SHARE OF THE CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION (2016)
  • FIGURE 19: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE CONTRAST MEDIA INJECTOR MARKET
  • FIGURE 20: NORTH AMERICA: CONTRAST MEDIA INJECTOR MARKET SNAPSHOT
  • FIGURE 21: PREVALENCE OF ALZHEIMER'S DISEASE IN THE U.S., BY AGE GROUP, 2015
  • FIGURE 22: EUROPE: CONTRAST MEDIA MARKET SNAPSHOT
  • FIGURE 23: ASIA-PACIFIC: CONTRAST MEDIA INJECTOR MARKET SNAPSHOT
  • FIGURE 24: ROW: CONTRAST MEDIA MARKET SNAPSHOT
  • FIGURE 25: KEY DEVELOPMENTS OF THE PROMINENT PLAYERS IN THE CONTRAST MEDIA INJECTOR MARKET (2013-2016)
  • FIGURE 26: OTHER STRATEGIES - KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM 2013 TO 2016
  • FIGURE 27: PRODUCT MIX OF THE PROMINENT PLAYERS IN THE CONTRAST MEDIA INJECTOR MARKET
  • FIGURE 28: BAYER HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 29: BRACCO IMAGING S.P.A: COMPANY SNAPSHOT (2015)
  • FIGURE 30: GUERBET GROUP: COMPANY SNAPSHOT (2015)
  • FIGURE 31: ANGIODYNAMICS: COMPANY SNAPSHOT (2015)
  • FIGURE 32: GE HEALTHCARE: COMPANY SNAPSHOT
Back to Top